Why a Global Action Plan on dementia is so important

Originally published 19 December on the Biomed Central Network. Dementia is the name of a group of progressive diseases that affect cognition and other crucial functions of the brain. Alzheimer’s disease is the most common cause of dementia, followed by vascular dementia, dementia with Lewy bodies and Frontotemporal dementia (FTD). Age is the main risk … More Why a Global Action Plan on dementia is so important

Alzheimer community between disappointment and hope regarding drug development at CTAD conference 2016

Executive Director Marc Wortmann reviews progress in new drug developments for Alzheimer’s Disease at the 9th Clinical Trials in Alzheimer’s Disease Conference (CTAD) in December 2016. … More Alzheimer community between disappointment and hope regarding drug development at CTAD conference 2016

Support in Oman

My own personal experience of dementia began when my mother seemed to forget where she had put her things. Initially, we as a family assumed that this was simply a normal part of ageing, but gradually she started forgetting where she was and could not recognize the people around her, often repeating questions that we … More Support in Oman

Finding strength through support groups

Alzheimer’s Association of Israel, or EMDA, is a non-profit organization founded by family members of people living with dementia, which aims to support these families. One of the services offered are caregiver support groups. Through the groups, carers can access information on the disease and how to deal with the health and social care systems. … More Finding strength through support groups

A look back at 2015

2015 was another busy year for Alzheimer’s Disease International (ADI), working alongside our extensive network of Alzheimer associations to make dementia a global health priority. These achievements mark another significant step forward to realising our vision of a better world for people living with dementia and their carers. In March the World Health Organization (WHO) … More A look back at 2015

Melissa’s story

I was about 14 when my dad was diagnosed with early onset Alzheimer’s disease. The doctors attributed it to the belated emergence of effects from an accident he had when he was younger. For the next 10 years, I lived everyday seeing my father fight the disease and the family’s struggle to redefine normalcy, until … More Melissa’s story